Interferon-Α Immunotherapy, Combined with Praziquantel Downregulates VEGF Gene Expression, Causing Regression of Hepatic Fibrosis in Chronic Schistosoma Mansoni Experimental Infec - Egyptian Knowledge Bank

241768

Interferon-Α Immunotherapy, Combined with Praziquantel Downregulates VEGF Gene Expression, Causing Regression of Hepatic Fibrosis in Chronic Schistosoma Mansoni Experimental Infec

Article

Last updated: 03 Jan 2025

Overview Similar Items

Article

Effect of Interferon-α Immunotherapy, Combined with Albendazole on The Integrity of Hydatid Cysts’ Germinal Epithelium: Experimental Study

Article

Regulation of Liver Fibrosis during Murine Schistosomiasis Mansoni

Article

CLOVE OIL OR COMBINED WITH PRAZIQUANTEL DOWN REGULATED TGF-Β1 AND REVERSED FIBROGENIC DYNAMIC PROGRESSION CAUSED BY CHRONIC SCHISTOSOMIASIS MANSONI IN MICE

Article

Pentoxifylline and/or praziquantel reduce murine schistosomiasis mansoni histopathology via amelioration of liver functions

Article

Interlukin -17 Promotes Granuloma Formation and Epithelial- Mesenchymal Transition (EMT) of Hepatic Cells in Experimental Schistosomiasis mansoni

Article

Human Platelet Rich Plasma Alleviates Liver Fibrosis in Murine Schistosomiasis Mansoni

Article

Efficacy of Pentoxifylline as an Antifibrotic Drug in Experimental Murine Schistosomal Hepatic Fibrosis

Article

Vascular Endothelial Growth Factor (VEGF): An Important Marker of Cure Progression in Schistosomiasis Mansoni Disease

Article

Angiotensin-Converting Enzyme Inhibitor “Lisinopril” Antagonizes Hepatic TGF-β1, improving Hepatic Fibrosis Caused by Experimental Schistosomiasis mansoni

Article

The role of interleukin-2 and interleukin-4 in disease progression in patients with schistosomiasis combined with chronic viral hepatitis C and chronic viral hepatitis B